生物活性 | |||
---|---|---|---|
描述 | Limantrafin (CB-103) is a pioneering, orally bioavailable inhibitor of protein-protein interaction (PPI) targeting the NOTCH transcriptional activation complex. Limantrafin exhibits antitumor efficacy[1][2][3][4]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
4.13mL 0.83mL 0.41mL |
20.63mL 4.13mL 2.06mL |
41.27mL 8.25mL 4.13mL |
参考文献 |
---|
[2]R.Lehal, et al. Development of a novel first-in-class oral inhibitor of the NOTCH pathway. |